- Home
- CTSO vs BMR Comparison
CTSO vs BMR Comparison
Compare CTSO & BMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- BMR
- Stock Information
- Founded
- CTSO 1997
- BMR 2009
- Country
- CTSO United States
- BMR Israel
- Employees
- CTSO N/A
- BMR N/A
- Industry
- CTSO Medical/Dental Instruments
- BMR Computer Software: Prepackaged Software
- Sector
- CTSO Health Care
- BMR Technology
- Exchange
- CTSO Nasdaq
- BMR Nasdaq
- Market Cap
- CTSO 51.6M
- BMR 59.3M
- IPO Year
- CTSO N/A
- BMR 2023
- Fundamental
- Price
- CTSO $1.03
- BMR $3.87
- Analyst Decision
- CTSO Strong Buy
- BMR
- Analyst Count
- CTSO 3
- BMR 0
- Target Price
- CTSO $4.67
- BMR N/A
- AVG Volume (30 Days)
- CTSO 538.8K
- BMR 716.0K
- Earning Date
- CTSO 03-06-2025
- BMR 08-06-2024
- Dividend Yield
- CTSO N/A
- BMR N/A
- EPS Growth
- CTSO N/A
- BMR N/A
- EPS
- CTSO N/A
- BMR N/A
- Revenue
- CTSO $37,739,531.00
- BMR $2,955,000.00
- Revenue This Year
- CTSO $9.20
- BMR $21.52
- Revenue Next Year
- CTSO $11.64
- BMR N/A
- P/E Ratio
- CTSO N/A
- BMR N/A
- Revenue Growth
- CTSO 1.80
- BMR 2.25
- 52 Week Low
- CTSO $0.70
- BMR $1.41
- 52 Week High
- CTSO $1.59
- BMR $34.94
- Technical
- Relative Strength Index (RSI)
- CTSO 55.82
- BMR 48.56
- Support Level
- CTSO $1.00
- BMR $4.25
- Resistance Level
- CTSO $1.14
- BMR $4.23
- Average True Range (ATR)
- CTSO 0.09
- BMR 0.75
- MACD
- CTSO 0.01
- BMR -0.11
- Stochastic Oscillator
- CTSO 64.40
- BMR 11.69
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales, Distributors/strategic partners, and Government segments. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About BMR Beamr Imaging Ltd.
Beamr Imaging Ltd is a video technology and image science software company. It is an innovator of video encoding, transcoding, and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and images. The company is conducted through one operating segment, the optimization technology for video and photo compression. The company operates in Israel, the United States, and the rest of the world, it derives a majority of its revenue from the United States.